MDSL
TEVA icon

M.D. Sass LLC’s Teva Pharmaceuticals TEVA Stock Holding History

M.D. Sass LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-64,800
Closed -$2.35M – 54
2016
Q4 		$2.35M Buy
64,800
+10,200
+19% +$407K 0.13% 48
2016
Q3 		$2.51M Sell
54,600
-42,400
-44% -$2.21M 0.14% 43
2016
Q2 		$4.87M Sell
97,000
-400
-0.4% -$21.3K 0.24% 38
2016
Q1 		$5.21M Sell
97,400
-622
-0.6% -$36.5K 0.28% 34
2015
Q4 		$6.43M Buy
98,022
+9,506
+11% +$587K 0.35% 28
2015
Q3 		$5M Sell
88,516
-295
-0.3% -$19.1K 0.28% 37
2015
Q2 		$5.25M Buy
88,811
+6,011
+7% +$371K 0.26% 38
2015
Q1 		$5.16M Buy
82,800
+30,900
+60% +$1.8M 0.26% 37
2014
Q4 		$2.98M Sell
51,900
-9,008
-15% -$502K 0.18% 44
2014
Q3 		$3.27M Buy
60,908
+47,988
+371% +$2.54M 0.19% 43
2014
Q2 		$677K Buy
12,920
+7,507
+139% +$384K 0.04% 42
2014
Q1 		$286K Sell
5,413
-1,200
-18% -$55.5K 0.02% 47
2013
Q4 		$265K Sell
6,613
-603,304
-99% -$23.8M 0.02% 44
2013
Q3 		$23M Buy
609,917
+572,117
+1,514% +$22.3M 1.82% 30
2013
Q2 		$1.48M Buy
+37,800
New +$1.47M 0.12% 39

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

M.D. Sass LLC's TEVA Position: Q1 2017 in Review

M.D. Sass LLC sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 64,800 shares — an estimated $2.35M sold.

M.D. Sass LLC first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $23M in Q3 2013. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • M.D. Sass LLC reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • M.D. Sass LLC sold 64,800 Teva Pharmaceuticals shares in Q1 2017, an estimated $2.35M.
  • M.D. Sass LLC first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • M.D. Sass LLC's Teva Pharmaceuticals position peaked at $23M in Q3 2013.
  • 688 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on M.D. Sass LLC's 13F filing for Q1 2017, filed 12 May 2017.